CSF2 and neoplasm: In the context of delivering an immunomodulatory gene sequence, most viral vectors deliver a single gene (e.g. GM-CSF, IL-12, or IFN-α2b) and conflicting data raise questions as to whether this is sufficient for immune activation robust enough to break peripheral tolerance to tumor antigens.